Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:4 Number:215 ISSN#:2563-5476
RCT
ACE Report #339
Ace Report Cover Spine

Allogenic cancellous bone use in monosegmental spondylodesis


How to Cite

OrthoEvidence. Allogenic cancellous bone use in monosegmental spondylodesis. ACE Report. 2013;2(4):215. Available from: https://myorthoevidence.com/AceReport/Report/339

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: A randomized prospective study

Eur Spine J. 2009 May;18(5):687-95. Epub 2009 Jan 16

Contributing Authors: M Putzier P Strube JF Funk C Gross HJ Mönig C Perka A Pruss

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

44 patients suffering monosegmental ventrodorsal spondylodesis were randomized to receive either autogenous corticocancellous iliac crest bone or allogenic cancellous bone for lumbar fusion, assessing the non-inferiority of the use of allogenic cancellous bone. The results from this study indicated that treatment with allogenic cancellous bone was equivalent to autogenous corticocancellous iliac c...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.